Topiramate Therapy in Alternating Hemiplegia of Childhood

Kasinathan A, Sharawat IK, Sahu JK, Sankhyan N. “Topiramate Therapy in Alternating Hemiplegia of Childhood.” Indian Journal of Pediatrics. 2017 Dec; 84;(12): 957-958.

Kwon YJ, Falk MJ, Bennett MJ. “Flunarizine rescues reduced Lifespan in CLN3 Triple Knock-out Caenorhabditis Elegans Model of Batten Disease.” Journal of Inherited Metabolic Disease (October 20, 2016).

Lai KL, Niddam DM, Fuh JL, Chen SP, Wang YF, Chen WT, Wu JC, Wang SJ. “Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis: A Randomized Trial.” Acta Neurologica Scandinavica (June 16, 2016).

Mohamed BP, Goadsby J, Prabhakar P. “Safety and Efficacy of Flunarizine in Childhood Migraine: 11 Years’ Experience, with Emphasis on its Effect in Hemiplegic Migraine.” Developmental Medicine & Child Neurology (January 23, 2012).

Pledger GW. “Flunarizine for Treatment of Partial Seizures: Results of a Concentration-Controlled Trial.” Neurology 44, no.10 (1994): 1830-1836.

Sasaki M, Ishii A, Saito Y, Morisada N, et al. “Genotype-Phenotype Correlations in Alternating Hemiplegia of Childhood.” Neurology (January 15, 2014).

Aishworiya R, Low P, Tay S. “Alternating Hemiplegia of Childhood: Successful Treatment with Topiramate and Flunarizine, a Case Report.” Annals of Tropical Paediatrics 31, no. 2 (2011): 149-152.

Sasaki M, Sakuragawa N, Osawa M. “Long-term Effect of Flunarizine on Patients with Alternating Hemiplegia of Childhood in Japan.” Brain Development 23, no. 5 (August 2001): 303-305.

Alexoudi A, Schneider SA. “Alternating Hemiplegia of Childhood and Rapid-onset Dystonia Parkinsonism are Allelic Disorders due to ATP1A3 Gene Mutations.” Movement Disorders (October 2012): 1494-.

Shinde V, Yegnanarayan R, Shah P, Gupta A, Pophale P. “Antidepressant-Like Activity of Flunarizine in Modified Tail Suspension Test in Rats.” North American Journal of Medical Sciences 7, no. 3 (March 2015): 100-3.